Table 2.
Group Comparison | Canonical Pathway | P Value |
z Scorea |
---|---|---|---|
D+ versus D− | Complement system | .007 | 2.0 |
D+ UTI+ versus | None | n/a | n/a |
D− UTI + | |||
D+ UTI− versus | elF4 and p70S6K | .01 | 2 |
D− UTI− | |||
UTI+ versus UTI− | Interferon | .002 | 2.5 |
Actin cytoskeleton | .00002 | −3.3 | |
Integrin | 8.7 × I0−8 | −2.9 | |
Paxillin | .0003 | −2.3 | |
RhoA | .0004 | −2.3 | |
D+ UTI+ versus | Interferon | .00004 | 2.5 |
D+ UTI− | Actin cytoskeleton | .004 | −2.5 |
Integrin | .002 | −2.5 | |
Paxillin | .003 | −2.5 | |
Glioma invasiveness | .004 | −2.2 | |
D− UTI+ versus | None | n/a | n/a |
D− UTI− |
Abbreviations: D+, delirious; D−, not delirious; n/a, not applicable; UTI+, urinary tract infection present; UTI−, urinary tract infection absent.
z score: A positive z score indicates upregulation of the pathway. A negative z score indicates downregulation of the pathway.